Metrics to compare | 012790 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship012790PeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.3x | 2.3x | −0.4x | |
PEG Ratio | −0.21 | −0.07 | 0.00 | |
Price/Book | 0.4x | 0.6x | 2.6x | |
Price / LTM Sales | 0.8x | 0.6x | 3.1x | |
Upside (Analyst Target) | - | 0.0% | 48.2% | |
Fair Value Upside | Unlock | 19.3% | 5.8% | Unlock |
Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.